Picture of Chronoscale logo

CHRN Chronoscale News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

Ekso Bionics Holdings Inc expected to post a loss of 13 cents a share - Earnings Preview

* Ekso Bionics Holdings Inc  EKSO.OQ   EKSO.O  is expected
to show
a rise in quarterly revenue when it reports  results on July 29
for the period ending June 30 2024
    * The San Rafael California California-based  company is
expected
to report a 10.0% increase in revenue to $5.171 million from
$4.7 million a year ago, according to the mean estimate from 2
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Ekso Bionics Holdings
Inc is
for a loss of 13 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Ekso
Bionics
Holdings Inc is $6.25​, above​ its last closing price of $1.25.
​​​

This summary was machine generated July 23 at 11:40 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Chronoscale

See all news